New Delhi metallo-β-lactamase-1 catalyses avibactam and aztreonam hydrolysis.
Metallo-β-lactamases (MBLs) threaten the clinical utility of β-lactam antibiotics by hydrolysing penicillins, cephalosporins, and carbapenems
Auteurs principaux: | Lohans, C, Brem, J, Schofield, C |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
American Society for Microbiology
2017
|
Documents similaires
-
New Delhi metallo-beta-lactamase 1 catalyzes avibactam and aztreonam hydrolysis
par: Lohans, C, et autres
Publié: (2017) -
Aztreonam Combinations with Avibactam, Relebactam, and Vaborbactam as Treatment for New Delhi Metallo-β-Lactamase-Producing Enterobacterales Infections—In Vitro Susceptibility Testing
par: Małgorzata Brauncajs, et autres
Publié: (2024-03-01) -
In Vitro Susceptibility of Aztreonam-Vaborbactam, Aztreonam-Relebactam and Aztreonam-Avibactam Associations against Metallo-β-Lactamase-Producing Gram-Negative Bacteria
par: Cécile Emeraud, et autres
Publié: (2023-09-01) -
Interaction of Avibactam with Class B Metallo-β-Lactamases.
par: Abboud, M, et autres
Publié: (2016) -
Evaluation of a simple method for testing aztreonam and ceftazidime-avibactam synergy in New Delhi metallo-beta-lactamase producing Enterobacterales.
par: Salman Khan, et autres
Publié: (2024-01-01)